Herbst Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Herbst Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,000	Closed	-$610K	–	73
2025 Q4	$610K	Buy	5,000 +275	+6%	+$31.5K	0.36%	53
2025 Q3	$473K	Hold	4,725	–	–	0.29%	46
2025 Q2	$392K	Sell	4,725 -5	-0.1%	-$399	0.23%	46
2025 Q1	$384K	Sell	4,730 -100	-2%	-$8.94K	0.27%	46
2024 Q4	$435K	Buy	4,830 +800	+20%	+$77.5K	0.27%	54
2024 Q3	$398K	Hold	4,030	–	–	0.25%	53
2024 Q2	$374K	Hold	4,030	–	–	0.23%	59
2024 Q1	$382K	Buy	4,030 +100	+3%	+$9.28K	0.24%	57
2023 Q4	$351K	Hold	3,930	–	–	0.23%	58
2023 Q3	$287K	Sell	3,930 -331	-8%	-$26.4K	0.2%	63
2023 Q2	$355K	Buy	4,261 +11	+0.3%	+$920	0.25%	62
2023 Q1	$324K	Buy	4,250 +20	+0.5%	+$1.66K	0.23%	65
2022 Q4	$351K	Hold	4,230	–	–	0.28%	62
2022 Q3	$336K	Hold	4,230	–	–	0.28%	65
2022 Q2	$324K	Buy	+4,230	New	+$318K	0.26%	67

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Herbst Group's XBI Position: Q1 2026 in Review

Herbst Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2026, closing a stake of 5,000 shares — an estimated $610K sold.

Herbst Group first reported a position in XBI in Q2 2022 and held it in 15 quarters. The position peaked at $610K in Q4 2025. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Herbst Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2026 after selling out during the quarter.
Herbst Group sold 5,000 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $610K.
Herbst Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 15 quarters.
Herbst Group's State Street SPDR S&P Biotech ETF position peaked at $610K in Q4 2025.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Herbst Group's 13F filing for Q1 2026, filed 9 Apr 2026.